Skip to content

SPF of Asaya Spot Light Sunscreen SPF 50 PA ++++

An In- Vivo study to determine the Sun Protection Factor of Asaya Spot Light Sunscreen SPF 50 PA ++++. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101167
Enrollment
10
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product:Asaya Spot Light Sunscreen SPF 50 PA++++: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Not Applicable: Not

Sponsors

Wellspring Consumer Private Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individual should have ITA angle in the range of 18 t0 40, 41 to 55, and greater than 56 2. Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator. 3. Individuals who have completed a preliminary medical history evaluation. 4. Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing. 5. Individuals with no known abnormal response to sunlight.

Exclusion criteria

Exclusion criteria: 1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results. 2.Individuals with chronic skin allergies. 3.Individuals with suntan or sunburn. 4.Individuals with abnormal reaction to the sun. 5.Pregnant or lactating females. 6.Subjects accustomed to using sun beds. 7.Subjects who have participated in an SPF study within the last two months.

Design outcomes

Primary

MeasureTime frame
Change in Individual MED (iMED) scoreTimepoint: Day 1,Day 2,Day 3

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026